Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial
STZ/5-FU and everolimus were not statistically different in PFS rates, but STZ/5-FU achieved higher response rates.
Authors
- François‐Xavier Caroli‐Bosc (ORCID: https://orcid.org/0000-0002-9881-0831)
- Aldo Scarpa
- Annamaria Colao (ORCID: https://orcid.org/0000-0001-6986-266X)
- Naureen Starling (ORCID: https://orcid.org/0000-0002-1496-6792)
- L. Vestermark
- Merete Krogh (ORCID: https://orcid.org/0000-0002-2410-9559)
- Salvatore Tafuto (ORCID: https://orcid.org/0000-0002-3019-354X)
- Elizaveta Mitkina Tabaksblat
- Vicente Valentí (ORCID: https://orcid.org/0000-0002-2963-7713)
- Anja Rinke (ORCID: https://orcid.org/0000-0002-8156-2915)
- Isabel Sevilla (ORCID: https://orcid.org/0000-0001-6942-159X)
- Carlo Carnaghi (ORCID: https://orcid.org/0000-0002-8286-3728)
- Alberto Carmona‐Bayonas (ORCID: https://orcid.org/0000-0002-1930-9660)
- J-P. Metges
- Chanthirika Ragulan (ORCID: https://orcid.org/0000-0002-9520-4844)
- Judith de Vos‐Geelen (ORCID: https://orcid.org/0000-0003-2578-1766)
- J. Schrader (ORCID: https://orcid.org/0000-0002-1298-9755)
- Ramón Salazar (ORCID: https://orcid.org/0000-0001-9419-6232)
- Alexander von Werder
- José Luís Zamora Manzano (ORCID: https://orcid.org/0000-0002-8987-4577)
- Paula Jiménez‐Fonseca (ORCID: https://orcid.org/0000-0003-4592-3813)
- Rita T. Lawlor (ORCID: https://orcid.org/0000-0003-3160-0634)
- Rocio García‐Carbonero (ORCID: https://orcid.org/0000-0002-3342-397X)
- Henning Jann (ORCID: https://orcid.org/0000-0003-4095-336X)
- Ulrich Knigge (ORCID: https://orcid.org/0000-0001-5930-0903)
- Birgit Cremer
- Heinz‐Josef Klümpen (ORCID: https://orcid.org/0000-0002-7290-1823)
- Anguraj Sadanandam (ORCID: https://orcid.org/0000-0001-8485-5150)
- Nicholas Reed (ORCID: https://orcid.org/0000-0003-4498-5190)
- P. Ruszniewski
- Marino Venerito (ORCID: https://orcid.org/0000-0001-8581-0974)
- Hari PS (ORCID: https://orcid.org/0000-0003-3580-962X)
- Denis Smith (ORCID: https://orcid.org/0000-0003-3155-6709)
- Àlex Teulé (ORCID: https://orcid.org/0000-0003-0028-7200)
- J. Hernando
- Dieter Hörsch (ORCID: https://orcid.org/0000-0002-4872-4337)
- María Ángeles Martín (ORCID: https://orcid.org/0000-0001-8173-4521)
- V. Navarro
- Eric Baudin
- Bengt O. Eriksson
- Marta Benavent
- J. Capdevila
Institutions
- University of Verona (IT)
- Hebron University (PS)
- Royal Marsden NHS Foundation Trust (GB)
- Humanitas University (IT)
- Uppsala University Hospital (SE)
- Institute of Cancer Research (GB)
- Universität Hamburg (DE)
- Philipps University of Marburg (DE)
- Université Paris Cité (FR)
- Universitätsklinikum Gießen und Marburg (DE)
- Hôpital Beaujon (FR)
- Maastricht University Medical Centre (NL)
- Beatson West of Scotland Cancer Centre (GB)
- Odense University Hospital (DK)
- Hospital de Sant Pau (ES)
- Institut Gustave Roussy (FR)
- Aarhus University Hospital (DK)
- TUM Klinikum (DE)
- Rigshospitalet (DK)
- LMU Klinikum (DE)
- Hospital General Universitario Morales Meseguer (ES)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hospital Universitario 12 De Octubre (ES)
- Zentralklinik Bad Berka (DE)
- Institut Català d'Oncologia (ES)
- Klinikum Magdeburg (DE)
- Amsterdam Neuroscience (NL)
- University Medical Center Hamburg-Eppendorf (DE)
- Hôpital Saint-André (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Vall d'Hebron Hospital Universitari (ES)
- Centre Hospitalier Régional Universitaire de Brest (FR)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Central de Asturias (ES)
- Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Duran i Reynals Hospital (ES)
- Centrum für Integrierte Onkologie (DE)
- Amsterdam University Medical Centers (NL)
- Instituto de Investigación Biomédica de Málaga (ES)
- Charité - Universitätsmedizin Berlin (DE)
- University of Amsterdam (NL)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.105922
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00